Introduction: Very few studies have been conducted to evaluate the prevalence of hyperuricemia and its impact on the prognosis amongst acute
Introduction
Stroke is the second leading cause of death and the leading cause of adult disability worldwide [1, 2] . Stroke ranks 6 th out of the top ten causes of death and accounts for one of the top frequent neurological disease consulting at the neurology units [3] . The burden of stroke seems to be shifting to the developing world and currently two-thirds of stroke mortality cases occur in sub-Saharan Africa [4, 5] . In Africa, stroke case fatality ranges from 31.9% to as high as 69.7% when due to hemorrhagic stroke [6] [7] [8] . Uric acid is a powerful anti-oxidant that exerts neuroprotective effects by acting as a free radical scavenger in plasma [9] [10] [11] . It has been reported that increased levels of uric acid are associated with established cardiovascular risk factor such as elevated serum triglyceride and cholesterol concentration, hypertension, obesity, insulin resistance and metabolic syndrome [9, 12] . The role of SUA in acute stroke is poorly understood since some studies demonstrate that SUA is associated with adverse outcomes and mortality [13] [14] [15] [16] [17] [18] while other studies are suggesting that SUA may be beneficial and protect against poor outcomes [19, 20] . Despite these controversies as to whether there is a relation between SUA levels and outcome after acute stroke, the role of SUA in the acute phase of hemorrhagic stroke only has received scant attention in world literature.
Therefore, in this study we estimated the prevalence of hyperuricemia in hemorrhagic stroke and determined its relationship with CVRFs and stroke outcome within 3 months post stroke onset.
Methods
Patients and study design: We carried out a hospital based prospective cohort study in a tertiary care hospital in Douala, Cameroon. We included consenting patients admitted for hemorrhagic stroke in the neurology unit of the department of internal medicine and the intensive care unit of the Douala General Hospital (DGH) from January 2010 to January 2016. This study was approved by the Institutional Ethics Committee of Research on
Human Health of the University of Douala and the study hospital-DGH. Patients who were admitted for confirmed hemorrhagic stroke within 7 days of onset of symptoms were included in our study.
Patients with incomplete files, acute ischemic stroke and cerebral venous thrombosis were excluded. 
Results
Basic characteristics of the study population: Table 1 shows the basic characteristics of the study population: A total of 221 patients with hemorrhagic stroke were included amongst which 134
were males (60.6%). The mean age was 55.8±11.8 years with most patients aged 46-60 years (49.8%). Table 1 Comparison of SUA levels with CVRFs amongst hemorrhagic stroke patients: Table   5 ).
Discussion
According to our findings, we observed that the prevalence of hyperuricemia amongst hemorrhagic stroke patients was 34.4% in stroke patients in the Ghanaian study [14] . This difference can be accounted for by differences in the methodology and the sample size in the Ghanaian study was small (147). Therefore, it is possible to conclude that this high prevalence of hyperuricemia may simply reflect its association or correlation with CVRFs present amongst hemorrhagic stroke patients.
In our study, we found no statistically significant correlation between SUA level and NIHSS and between SUA level and mRS in hemorrhagic stroke. We also noted a weak negative significant correlation between Glasgow coma score and SUA concentration. syndrome. Regardless of these findings, it is therefore possible to imply that hyperuricemia is a possible risk factor for stroke and primary prevention of stroke will be crucial in the reduction of mortality and morbidity related to hemorrhagic stroke amongst Cameroonians. The strength of this study was the fact that we prospectively explored different aspects of stroke outcomes in relation to uric acid amongst a cohort of patients with ICH but as a limitation, we were not able to explore certain variables that could have been more appropriate such the glycated hemoglobin (HbA1c).
We used blood glucose levels in the study instead of the HbA1c hence overestimating the proportion of patients with diabetes mellitus as stress hyperglycemia could occur in acute conditions such as stroke. Despite these limitations, we have been able to assess the relationship between uric acid and stroke outcome.
Conclusion
Our findings suggest that one third of patients present with hyperuricemia in the acute phase of hemorrhagic stroke.
Hyperuricemia can act as a risk factor for stroke because of its relationship with CVRFs but it is not an independent predictor of the mortality and adverse outcome amongst black African hemorrhagic stroke patients. 
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